Amanote Research

Amanote Research

    RegisterSign In

Targeting FGFR Signaling in Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2329
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

June 14, 2015

Authors
M. TouatE. IleanaS. Postel-VinayF. AndreJ.-C. Soria
Publisher

American Association for Cancer Research (AACR)


Related search

Targeting the PI3K Signaling Pathway in Cancer

Current Opinion in Genetics and Development
GeneticsDevelopmental Biology
2010English

Rational Targeting of Notch Signaling in Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Targeting Core Signaling Pathways in Pancreatic Cancer

Science-Business eXchange
2008English

Targeting NRF2 Signaling for Cancer Chemoprevention

Toxicology and Applied Pharmacology
ToxicologyPharmacology
2010English

Targeting the AXL Signaling Pathway in Ovarian Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2016English

Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways

Clinical Cancer Research
Cancer ResearchOncology
2010English

Bcl‐2 Inhibitors Enhance FGFR Inhibitor‐induced Mitochondrial‐dependent Cell Death in FGFR 2 Mutant Endometrial Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Targeting the CCL2-CCR2 Signaling Axis in Cancer Metastasis

Oncotarget
Oncology
2016English

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy